Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

Connecticut

Phase 2 colorectal cancer trials in Connecticut

5 Phase 2 colorectal cancer studies are recruiting participants at sites in 4 cities across Connecticut as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Connecticut city with a recruiting study

New Haven (3), Hartford (1), North Haven (1), Trumbull (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Connecticut

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    New Haven · Trumbull
    Registry record
    NCT04557449 · updated
  2. Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Memorial Sloan Kettering Cancer Center
    Recruiting in
    Hartford
    Registry record
    NCT04165772 · updated
  3. A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    New Haven
    Registry record
    NCT06820463 · updated
  4. Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Gilead Sciences
    Recruiting in
    North Haven
    Registry record
    NCT07527858 · updated
  5. A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Criterium, Inc.
    Recruiting in
    New Haven
    Registry record
    NCT06992258 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Connecticut on ClinicalTrials.gov.

Ask about studies in Connecticut

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call